OKYO Pharma (OKYO) Director John P. Brancaccio Receives 5,000-Share Award

What Happened John P. Brancaccio, a director of OKYO Pharma Ltd (ticker: OKYO), was granted 5,000 shares on July 21, 2026. The award is reported at $1.48 per share, for a total reported value of $7,385. The transaction is coded as an award/grant/acquisition (A) — a receipt of shares rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-21; reported price: $1.48 per share; shares received: 5,000; total value: $7,385.
• Form 4 filing date: 2026-07-23 (filed two days after the transaction, within the SEC’s two-business-day reporting window).
• Shares owned after the transaction: Not specified in the provided summary — consult the full Form 4 for total holdings.
• Footnotes/conditions (vesting, tax withholding, 10b5-1 plan): None disclosed in the provided data.
• Filing accession: 0001493152-26-034405 (see full SEC Form 4 for complete details).

Context Awarded shares are commonly used as board compensation or restricted stock grants and may be subject to vesting or transfer restrictions; they are not the same as an executive buying shares on the open market. Receipt of an award is informational about compensation but does not necessarily indicate immediate insider sentiment or intent to trade.